braf/mek inhibition as adjuvant treatment in melanoma
Published 5 years ago • 359 plays • Length 4:18Download video MP4
Download video MP3
Similar videos
-
7:23
melanoma: braf/mek-inhibitors as adjuvant therapy
-
11:00
prosecution: argument for braf/mek-targeted adjuvant treatment of stage iii melanoma
-
2:10
combined treatment with braf and mek inhibitors in metastatic melanomas with braf mutations
-
6:23
adjuvant therapy options in melanoma treatment
-
1:30
adjuvant therapy for high-risk melanoma
-
8:47
braf/mek inhibitors in metastatic melanoma
-
17:55
adjuvant therapy for melanoma - amaria
-
27:28
advances in therapy for braf-mutant melanoma
-
1:28
jeffrey weber, md, phd: the impact of braf/mek inhibitors in melanoma
-
8:47
adjuvant therapy in melanoma: targeted vs immuno-oncology
-
2:40
neoadjuvant targeted therapy in braf v600 mutated melanoma
-
7:59
keynote022: triplet therapy for braf melanoma
-
8:40
melanoma: braf/mek targeted therapy
-
6:22
braf and mek in melanoma
-
1:30
molecular testing in stage 3 melanoma
-
4:14
adjuvant therapy for melanoma: novel treatment options
-
6:44
case 2: long-term braf/mek data in melanoma
-
1:57
dr. flaherty discusses braf inhibitors in melanoma
-
1:19
dr. postow on braf and mek inhibitor combination studies in melanoma